Paul B. Manning, Director, 10% Owner at Taysha Gene Therapies, Inc. (TSHA), bought 2,202 shares at $13.19 ($29K) on 2021-11-24, disclosed to the SEC on 2021-11-29.
Open-market purchase of $29k TSHA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| VRCA | BUY | 2025-11-25 | $35.0M | — | Filing → |
| LQDA | SELL | 2025-09-02 | $37.9M | — | Filing → |
| TSHA | BUY | 2025-06-03 | $2.1M | — | Filing → |